Mundisal (Choline Salicylate)

Choline salicylate works by reversibly inhibiting cyclooxygenase enzymes (COX‑1 and COX‑2). This inhibition reduces the production of prostaglandins, which are chemicals that trigger inflammation, pain, and fever, thereby providing local analgesic and anti‑inflammatory effects in the mouth.

The appropriate dose of Mundisal is determined by the prescribing healthcare professional based on the specific condition, severity, and patient factors. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety of Mundisal in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and only after consultation with a qualified healthcare provider.

To order Mundisal, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mundisal delivers choline salicylate directly to the oral mucosa, offering targeted pain relief with lower systemic exposure compared with systemic NSAIDs such as ibuprofen. This local application can reduce the risk of systemic side effects while still providing effective anti‑inflammatory action.

Mundisal should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and efficacy.

Mundisal is applied directly to the affected oral area using the provided applicator or swab. The patient should spread a thin layer over the lesion or inflamed mucosa, avoiding excessive use, and follow any specific instructions from the prescriber.

Serious risks include allergic reactions such as rash, angioedema, or Stevens‑Johnson syndrome, as well as gastrointestinal bleeding, renal impairment, and hepatic dysfunction. Patients should seek immediate medical attention if they experience severe skin reactions, persistent vomiting, blood in stool, or sudden loss of kidney function.

Mundisal should not be used by individuals with a known hypersensitivity to salicylates or any component of the formulation. It is also contraindicated in patients with active gastrointestinal ulceration, severe renal or hepatic disease, and those taking anticoagulants without medical supervision.